Thursday, July 19, 2018
Company News: Page (1) of 1 - 04/16/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Earthmedz, the decentralized patient and doctor-driven cooperative will begin their ICO on April 20th, 2018

(April 16, 2018)

Earthmedz is the newly launched cooperative led by patients and guided by doctors that focuses on life-threatening diseases. The platform aimed at sourcing the best methodologies for delivering improved health outcomes for patients worldwide has announced that their official ICO will begin on April 20th, 2018. Its goal is to empower everyone, everywhere with knowledge and access to the best medical care in specialized medicine.

Through the ICO, Earthmedz will offer 150 million ETD tokens, which are based on Ethereum (ERC-20). The ICO will be held in four stages, with each stage offering one ETD token at a price of $0.12, $0.13, $0.14 and $0.15 respectively. The soft cap is $3M and the hard cap is $20.1M. The success of the ICO will ensure that the platform is able to follow its goal of providing the one of its kind decentralized healthcare solution for everyone in the world.

Earthmedz incorporates an ecosystem of healthcare-related services led by the whole community of patients, world’s leading doctors and specialists, caretakers and anyone who’s interested in contributing to improving health outcomes. It’s a common platform where the patients, medical practitioners, and the entire health ecosystem can connect directly with each other. The patient can be in one country and the specialist in another but through this platform, they’ll be able to communicate and the get solutions for their problems.

Using the power of blockchain technology, Earthmedz strives to build an interconnected ecosystem for healthcare where the efficiency of the processes and services are increased and where information is embedded in the digital code, stored in transparent, shared databases and securely protected from deletion, tampering, and revision.

This platform overcomes the shortcomings of the conventional healthcare system such as the limited access to the right medical care due to a shortage of specialists, issues of privacy and risks of data theft or hacking attacks. It focuses on bringing transparency to the healthcare by supporting and funding projects that map world’s leading specialists in life-threatening and rare conditions per country. This will enable the patients worldwide to find the right specialists.

Earthmedz is building a network of doctor specialists who would provide the patients with the right information before they take any major health decision. The Earthmedz ecosystem will be comprised of healthcare centers, hospitals, diagnostic labs, insurance organizations, pharmacies, research institutions, patient organizations and other stakeholders that could benefit from the ecosystem.

This system will also enhance healthcare experiences through better data collection and improved global research. More information about the platform and the upcoming ICO can be seen on

In case of any queries, drop a message to [email protected]




Bitcoin Talk:

Media Contact
Company Name: Earthmedz
Contact Person: Press Execuctive
Email: [email protected]
Country: Australia


Page: 1

Related Keywords:U.S,World,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research
  • Wireless Health Market To Witness Enhanced Growth Owing To Rising Application of Wireless Health Devices And Growing Patient-Centric Methodology Till 2025 | Million Insights

  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally -

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines